Literature DB >> 30903437

Allergic Comorbidity in Eosinophilic Esophagitis: Mechanistic Relevance and Clinical Implications.

Peter Capucilli1, David A Hill2,3.   

Abstract

Allergic eosinophilic esophagitis (EoE) is a chronic, allergen-mediated inflammatory disease of the esophagus, and the most common cause of prolonged dysphagia in children and young adults in the developed world. While initially undistinguished from gastroesophageal reflux disease-associated esophageal eosinophilia, EoE is now recognized as a clinically distinct entity that shares fundamental inflammatory features of other allergic conditions and is similarly increasing in incidence and prevalence. The clinical and epidemiologic associations between EoE and other allergic manifestations are well established. In addition to exaggerated rates of atopic dermatitis, IgE-mediated food allergy, asthma, and allergic rhinitis in EoE patients, each of these allergic manifestations imparts individual and cumulative risk for subsequent EoE diagnosis. As such, EoE may be a member of the "allergic march"-the natural history of allergic manifestations during childhood. Several determinants likely contribute to the relationship between these conditions, including shared genetic, environmental, and immunologic factors. Herein, we present a comprehensive review of allergic comorbidity in EoE. We discuss areas of the genome associated with both EoE and other allergic diseases, including the well-studied variants encoding thymic stromal lymphopoietin and calpain 14, among other "atopic" regions. We summarize ways that environmental factors (such as microbiome-altering pressures and aeroallergen exposure) may predispose to multiple allergic conditions including EoE. Finally, we touch on some fundamental features of type 2 inflammation, and the resulting implications for the development of multiple allergic manifestations. We conclude with an analysis of the "type 2" biologics, and how mechanistic similarities between EoE and the other allergic manifestations have important implications for screening and treatment of the allergic patient.

Entities:  

Keywords:  Allergic rhinitis; Asthma; Atopic dermatitis; Eosinophilic esophagitis; Food allergy

Mesh:

Substances:

Year:  2019        PMID: 30903437      PMCID: PMC6626558          DOI: 10.1007/s12016-019-08733-0

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  13 in total

Review 1.  Primary eosinophilic gastrointestinal disorders and allergy: Clinical and therapeutic implications.

Authors:  Carlo Maria Rossi; Marco Vincenzo Lenti; Stefania Merli; Amelia Licari; Martina Votto; Gian Luigi Marseglia; Antonio Di Sabatino
Journal:  Clin Transl Allergy       Date:  2022-05-23       Impact factor: 5.657

Review 2.  Eosinophilic esophagitis during sublingual and oral allergen immunotherapy.

Authors:  Joseph Cafone; Peter Capucilli; David A Hill; Jonathan M Spergel
Journal:  Curr Opin Allergy Clin Immunol       Date:  2019-08

3.  Peripheral markers of allergen-specific immune activation predict clinical allergy in eosinophilic esophagitis.

Authors:  Julianna Dilollo; Eric M Rodríguez-López; Leah Wilkey; Elizabeth K Martin; Jonathan M Spergel; David A Hill
Journal:  Allergy       Date:  2021-05-14       Impact factor: 13.146

4.  Conserved IFN Signature between Adult and Pediatric Eosinophilic Esophagitis.

Authors:  Melanie A Ruffner; Alex Hu; Julianna Dilollo; Kassidy Benocek; Donna Shows; Michael Gluck; Jonathan M Spergel; Steven F Ziegler; David A Hill; Karen Cerosaletti
Journal:  J Immunol       Date:  2021-02-08       Impact factor: 5.422

Review 5.  One march, many paths: Insights into allergic march trajectories.

Authors:  Stanislaw J Gabryszewski; David A Hill
Journal:  Ann Allergy Asthma Immunol       Date:  2021-05-07       Impact factor: 6.248

6.  Replication and meta-analyses nominate numerous eosinophilic esophagitis risk genes.

Authors:  Leah C Kottyan; Michael P Trimarchi; Xiaoming Lu; Julie M Caldwell; Avery Maddox; Sreeja Parameswaran; Michael Lape; Rahul J D'Mello; Madeline Bonfield; Adina Ballaban; Vincent Mukkada; Philip E Putnam; Pablo Abonia; Netali Ben-Baruch Morgenstern; Amy A Eapen; Ting Wen; Matthew T Weirauch; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2020-10-23       Impact factor: 14.290

7.  Mortality in Eosinophilic Esophagitis - a nationwide, population-based matched cohort study from 2005 to 2017.

Authors:  Lovisa Röjler; John J Garber; Bjorn Roelstraete; Marjorie M Walker; Jonas F Ludvigsson
Journal:  Ups J Med Sci       Date:  2021-08-31       Impact factor: 2.384

8.  The incidence of eosinophilic oesophagitis in 2007-2017 among children in North Denmark Region is lower than expected.

Authors:  Martin Hollænder; Jacob Holmen Terkelsen; Frederik Kramme; Kasper Bredal; Kristian Kragholm; Kasper Dalby; Søren Hagstrøm; Dorte Melgaard; Anne Lund Krarup
Journal:  BMC Pediatr       Date:  2022-04-06       Impact factor: 2.125

Review 9.  Diet Therapy in Eosinophilic Esophagitis. Focus on a Personalized Approach.

Authors:  Martina Votto; Maria De Filippo; Marco Vincenzo Lenti; Carlo Maria Rossi; Antonio Di Sabatino; Gian Luigi Marseglia; Amelia Licari
Journal:  Front Pediatr       Date:  2022-01-20       Impact factor: 3.418

10.  Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases.

Authors:  Jennifer D Hamilton; Sivan Harel; Brian N Swanson; William Brian; Zhen Chen; Megan S Rice; Nikhil Amin; Marius Ardeleanu; Allen Radin; Brad Shumel; Marcella Ruddy; Naimish Patel; Gianluca Pirozzi; Leda Mannent; Neil M H Graham
Journal:  Clin Exp Allergy       Date:  2021-06-26       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.